Bruker Daltonics to Host May 30th Press Conference at ASMS Mass Spectrometry Conference in Seattle.

BILLERICA, Mass. -- Bruker Daltonics today announced that it will hold a press conference at the American Society for Mass Spectrometry's 54th Annual Conference in Seattle, Washington, at which it plans to announce new mass-spectrometry based products for its pharmaceutical, molecular diagnostics, clinical proteomics and other life-science research customers.

Bruker Daltonics' ASMS press conference will take place on Tuesday, May 30th, from 2:15 p.m. to 3:15 p.m. in Media Room 615 at the Washington State Convention and Trade Center. Editors, journalists and institutional investors who plan to attend the press conference are asked to RSVP to [e-mail].

In addition, the company plans to hold technical workshops in Rooms 307 and 308, Monday through Wednesday, on small molecule analysis, advanced biomarker analysis, and proteomics advances. Starting at 12:30 each day, the workshops will also be open to the press. With space being limited, pre-registration at [e-mail] is recommended. Bruker Daltonics' speakers and other company scientists will be available for in-depth meetings during exhibit hours at booth 100, and each evening from 6:30 p.m. to 11:00 p.m. in the Westin Hotel Cascade II Ballroom.

For further information on the ASMS conference, please see www.asms.org.

ABOUT BRUKER BIOSCIENCES (NASDAQ: BRKR)

Bruker BioSciences Corporation, headquartered in Billerica, Massachusetts, is the publicly traded parent company of Bruker AXS Inc. and Bruker Daltonics Inc. Bruker AXS is a leading developer and provider of life science, materials research, and industrial X-ray analysis tools. Bruker Daltonics is a leading developer and provider of innovative life science tools based on mass spectrometry. For more information, please visit www.bruker-biosciences.com.